Showing results (31-40 of 242) with videos related to
Sort By:
Pageof 25
Cancer Cells (Cold Spring Harbor, N.Y. : 1989)|February 1, 1990
Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistanceP A Andrews, S B HowellThe American Journal of Medicine|February 1, 1976
Circulating immunoglobulin complexes in Wegener's granulomatosisS B Howell, W V EpsteinGynecologic Oncology|January 1, 1990
A review: intraperitoneal cisplatin in the management of patients with ovarian cancerE F McClay, S B HowellThe Journal of Biological Chemistry|August 23, 1996
Paclitaxel activation of the GADD153 promoter through a cellular injury response element containing an essential Sp1 binding siteD P Gately, S B HowellCancer Research|August 1, 1985
Mechanism of synergy between N-phosphonacetyl-L-aspartate and dipyridamole in a human ovarian carcinoma cell lineT C Chan, S B HowellCancer Treatment Reports|June 1, 1985
Pharmacokinetics of hexamethylmelamine administered via the Ip route in an oil emulsion vehicleA D Wickes, S B HowellEuropean Journal of Cancer & Clinical Oncology|April 1, 1989
Unexpected synergy between N-phosphonacetyl-L-aspartate and cytidine against human tumor cellsT C Chan, S B HowellCancer Treatment Reports|December 1, 1983
Phase I trial of cytarabine and hydroxyureaC E Pfeifle, S B HowellThe Journal of Pharmacology and Experimental Therapeutics|November 1, 1981
Pharmacological and therapeutic properties of carrier bound methotrexate against tumor confined to a third space body compartmentB C Chu, S B HowellProceedings of the National Academy of Sciences of the United States of America|August 1, 1981
Synergistic interaction between 1-beta-D-arabinofuranosylcytosine, thymidine, and hydroxyurea against human B cells and leukemic blasts in vitroJ A Streifel, S B HowellPageof 25